A coherence lens
on cancer.

This is not our main line of work. While building the coherence framework, one question kept surfacing in the biology literature: what if the onset of some cancers can be read as a coherence phase transition — a cell drifting past a critical coupling ratio and locking there? It was compelling enough to file a provisional patent on the method and start testing it honestly.

What follows is a hypothesis under investigation, not a clinical result. The patent covers a method for early detection, treatment optimization, and remission prediction; whether the underlying model holds is exactly what the data will decide. Decision-support and research only — never a substitute for licensed clinical care.

The filing.

The idea, stated plainly.

Model a healthy cell as sitting near a stable coupling ratio and self-correcting around it. The hypothesis is that malignancy begins when a single cell drifts past a critical threshold and loses that self-correction — locking into an aberrant state the tissue then inherits. These are the working pieces of that model; each is a claim to be tested, not a demonstrated fact.

The pre-lock window.

If the model is right, a malignant transformation would pass through a window in which a cell is drifting toward the aberrant state but has not yet locked — a window that might be both measurable and reversible. The steps below describe how the method would work if validated; none of it is a demonstrated clinical protocol.

What exists today.

Pre-registration locked before credentialed MIMIC-IV access. The statistical gates are set. The hypothesis is falsifiable. If the numbers don't hold in the prospective data, the framework is wrong — and that's exactly what a real physics theory has to say for itself.

Papers 143–151.

Eleven papers. One thread. Origin → observable → mechanism → phase transition → treatment → geometry → measurement → validation → driver → adjacent collapse.